Rockefeller Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-51,906
| Closed | -$953K | – | 1751 |
|
|
2024
Q4 | $953K | Buy |
+51,906
| New | +$953K | ﹤0.01% | 1265 |
|
|
2023
Q1 | – | Sell |
-29
| Closed | -$11K | – | 3970 |
|
|
2022
Q4 | $11K | Sell |
29
-37
| -56% | -$14K | ﹤0.01% | 3058 |
|
|
2022
Q3 | $22K | Sell |
66
-5
| -7% | -$1.67K | ﹤0.01% | 2736 |
|
|
2022
Q2 | $23K | Buy |
71
+6
| +9% | +$1.94K | ﹤0.01% | 2676 |
|
|
2022
Q1 | $28K | Hold |
65
| – | – | ﹤0.01% | 2586 |
|
|
2021
Q4 | $28K | Hold |
65
| – | – | ﹤0.01% | 2483 |
|
|
2021
Q3 | $36K | Buy |
65
+22
| +51% | +$12.2K | ﹤0.01% | 2308 |
|
|
2021
Q2 | $21K | Buy |
43
+15
| +54% | +$7.33K | ﹤0.01% | 2474 |
|
|
2021
Q1 | $21K | Sell |
28
-83
| -75% | -$62.3K | ﹤0.01% | 2268 |
|
|
2020
Q4 | $60K | Sell |
111
-28
| -20% | -$15.1K | ﹤0.01% | 1620 |
|
|
2020
Q3 | $63K | Hold |
139
| – | – | ﹤0.01% | 1431 |
|
|
2020
Q2 | $86K | Hold |
139
| – | – | ﹤0.01% | 1222 |
|
|
2020
Q1 | $66K | Sell |
139
-111
| -44% | -$52.7K | ﹤0.01% | 1156 |
|
|
2019
Q4 | $145K | Hold |
250
| – | – | ﹤0.01% | 851 |
|
|
2019
Q3 | $165K | Buy |
+250
| New | +$165K | ﹤0.01% | 669 |
|